Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Kelun-Biotech Announce Exclusive License Agreement For SKB378/HBM9378, an Anti-thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody (mAb).
2025-01-11 17:07
Corn Next Launches CornNext-17: A Groundbreaking Sustainable Solution to Plastic Pollution
2025-01-11 05:53
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
2025-01-10 22:00
Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases
2025-01-10 21:01
Psylo Rebrands as Xylo, with Key Board Appointments and Breakthrough Pipeline Progress
2025-01-10 21:00
JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in China as Second-line Treatment in Relapsed or Refractory adult Large B-cell Lymphoma
2025-01-10 17:00
Sciwind Biosciences Announces Global Licensing and Collaboration Agreement for Metabolic Disease Portfolio
2025-01-10 15:00
In 2024, Complete Genomics expanded U.S. manufacturing and technology capabilities toward a diversified, reliable supply chain for its flexible and cost-effective NGS solutions
2025-01-10 01:43
UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform
2025-01-09 16:41
RiDYMO® Designs Cyclic Peptide for "Undruggable" β-Catenin Target Within Two Months
2025-01-09 12:35
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development
2025-01-09 09:45
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development
2025-01-09 08:57
DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu
2025-01-09 03:48
Latest Updates of Viva Biotech's Portfolio Companies
2025-01-08 20:19
I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member
2025-01-08 20:00
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report
2025-01-08 16:12
GenScript Biotech Becomes a PSCI Supplier Partner, Advancing a Sustainable Pharmaceutical Supply Chain
2025-01-08 11:30
MedicosBiotech Wins CES 2025 Innovation Award in Digital Health
2025-01-08 01:00
Verismo Therapeutics Announces Strategic Partnership with IFLI to Support SynKIR™-310 Development in Follicular Lymphoma
2025-01-07 21:00
Alebund Pharmaceutical announced the 1st closing of RMB 550 million in Series C financing
2025-01-07 21:00
1
2
3
4
5
460